BPC-157 / TB-500 / GHK-Cu (Glow) 70mg

Research overview

The triple-peptide combination of BPC‑157, TB‑500, and GHK‑Cu—often referred to as the “Glow Protocol” or “Wolverine Stack”—is currently one of the most prominent systemic regenerative regimens in peptide research. Its three components act through complementary and overlapping pathways, addressing tissue repair at multiple levels: cellular regeneration, angiogenesis, and inflammatory modulation. BPC‑157 is a synthetic 15‑amino‑acid polypeptide derived from human gastric juice. Its primary actions include: promoting angiogenesis via the VEGFR2‑Akt‑eNOS pathway; enhancing fibroblast activity and collagen synthesis; facilitating cell migration and adhesion through FAK‑paxillin signalling; and modulating nitric oxide and various neurotransmitter systems. These effects translate into accelerated healing of muscle, tendon, ligament, bone, and gastrointestinal tissues. TB‑500, the active fragment of natural thymosin β4, operates by: binding to G‑actin to reorganise the cytoskeleton and promote cell migration; upregulating VEGF to stimulate neovascularisation; modulating cytokine profiles to curb inflammation; and inhibiting the Akt pathway, thereby exerting anti‑fibrotic activity. GHK‑Cu is a naturally occurring tripeptide‑copper complex first isolated from human plasma. Its distinctive role lies in deep gene‑expression regulation—it influences thousands of human genes, stimulates fibroblast production of collagen, elastin, and glycosaminoglycans, suppresses inflammation via JAK1 pathway downregulation, reduces reactive oxygen species, and delivers copper ions directly to damaged sites to facilitate tissue remodelling. When combined, BPC‑157 establishes the angiogenic and gastroprotective foundation; TB‑500 enhances cell migration and matrix remodelling; and GHK‑Cu orchestrates collagen synthesis and antioxidant defence at the transcriptional level. Together, they form an integrated repair network spanning vascular, cellular, and genetic tiers—a synergy that has attracted extensive research interest in regenerative medicine and tissue repair.